In 2009 Dr Mikovits led the team that first isolated and characterized a new family of human disease-associated retroviruses, XMRVs/HGRVS. Dr Mikovits has co-authored more than 50 peer reviewed publications and book chapters; holds patent # WO 2012061790 A1.
In 2020 Dr. Mikovits started DrJsolution, a company focused not only on education but on providing solutions for prevention and treatment autoimmune/auto-inflammatory diseases resulting from viral infection, drugs and environmental toxins. Her heart and passion is to focus on natural products chemistry and plant based drug therapies. Its current focus is on medical cannabis with breakthroughs in understanding of the pathophysiology of neuroimmune diseases as acquired endocannabinoid immune dysfunction (AEIDS).